Not Dead Yet: Controlled Non-Heart Beating Organ Donation, Consent, and the Dead Donor Rule
Introduction
The emergence of controlled, Maastricht Category III, Non-Heart Beating organ Donation (NHBD) programs 1 has the potential to greatly increase the supply of donor solid organs by increasing the number of potential donors. Category III donation involves unconscious and dying intensive care patients whose organs become available for transplant after life sustaining treatments are withdrawn, usually on grounds of futility. The shortfall in organs from Heart Beating organ Donation (HBD) 2 following brain death has prompted a surge of interest in NHBD. 345 In a recent editorial, the British Medical Journal described NHBD as representing "a challenge which the medical profession has to take up." 6 Criticism of controlled NHBD programs has mostly focussed on the criteria used for determining death, the potential for conflict of interests to arise for the treating physician in managing the dying patient, and the possibility that clinicians might violate the Dead Donor Rule (DDR) by hastening the death of the patient through the administration of drugs or interventions in treatment. 78910111213 We believe there is a more fundamental ethical concern with controlled NHBD. 14 We hold that the DDR is violated not just by donation practices which bring about the death of the patient but whenever clinicians treat the living donor as though they were dead. In controlled NHBD, because of the need for haste in salvaging organs before lack of circulation of oxygenated blood irreversibly damages them, there is a strong incentive to initiate surgical and/or institutional procedures to facilitate donation before death occurs. We argue that these medical procedures, which "treat" one patient for the benefit of another, represent a significant departure from the ethical practice of medicine. That the patient is likely to remain unaware of these interventions does not change this; the idea that it does, we suggest, relies on a surreptitious-and false!-claim that the patient is, for all intents and purposes, dead already. Controlled NHBD will therefore usually require violating the DDR.
The conclusion that NHBD will often violate the DDR is, perhaps, not as damning of the procedure as first appears, given recent criticism of the DDR by a number of eminent medical ethicists. It is possible that pre-mortem interventions might be justified with reference to the patient's-or an appropriate surrogate decision maker's-consent to organ donation. However, reminding ourselves that the patients involved in NHBD are "not dead yet" should draw our attention to significant implications of this fact for the level and nature of consent that is appropriate before these procedures can be undertaken ethically. Moreover, if the cost of embracing controlled NHBD is abandoning the DDR we believe that ethical debate about NHBD should be conducted in full awareness of this fact and not be foreclosed by any attempts to redefine death, or by naive appeals to utilitarian considerations.
I -Non-Heart Beating Organ Donation: Background and Practice
Unsurprisingly, when transplantation first became a viable option, the American Medical Association (AMA) insisted that vital organs should only be harvested from patients who were already dead. The "Dead Donor Rule" requires that the patient be dead-and be declared dead by a physician without any possible conflict of interest-before vital organs are harvested for donation. 151617 Prior to the acceptance of brain death, cadaveric donations were from patients who had been declared dead by traditional cardio-pulmonary criteria. The damage suffered by organs deprived of the circulation of oxygenated blood when the donor's heart stopped beating was a significant barrier to successful transplantation from such donors. However, the recognition of brain death as a criterion of death made it possible to source organs from persons who could be declared legally dead even though their hearts were still beating.
Recently, because of a shortage of organs for transplantation, there has been renewed interest in NHBD. Table 1 sets out the differences between controlled NHBD and HBD. Firstly, controlled non-heart beating donors have their mechanical ventilation and circulatory support withdrawn whilst they are still alive, whereas in HBD discontinuation occurs after the declaration of death. Secondly, NHBD involves greatly increased warm ischaemic time compared to HBD, since cardio-pulmonary failure must precede organ donation. 19 Attempts to improve the outcomes of transplants from NHB donors therefore, for the most part, focus on reducing the length and degree of warm ischaemic time. These attempts can be divided into two broad categories: those procedures that are initiated before the patient's heart has stopped beating and death has been declared and those that take place post-mortem.
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A number of means may be used to minimise warm ischaemic time after the patient's heart has stopped beating. Most obviously, the time between this moment and the cold perfusion of organs may be reduced by minimising the time between cessation of blood circulation and the declaration of death. This is achieved by using cardio-pulmonary death criteria that require that the pulse be absent for only a very short period of time before death can be declared. 21222324 Once death has been declared, intravenous medications to reduce damage to organs may be administered or the organs perfused with cold fluids while still in the body via a femoral catheter. Rarely, external heart compression and extracorporeal oxygenation may be initiated, in order to maintain organ function, right up to the time of organ retrieval.
25
The desire to reduce warm ischaemic damage to the donor organs has led to a much-compacted time frame for determining death in NHBD, which may, in some circumstances, introduce significant uncertainty in the diagnosis of death. 262728 However, this is not our main concern here, which is the nature and ethical significance of those interventions that occur before death.
The nature of pre-mortem interventions in NHBD varies between nations.
In the United States of America (USA) pre-mortem intervention is the norm. Life-sustaining treatment is usually withdrawn in the operating theatre instead of the intensive care unit in order to minimise the time between the declaration of death and organ retrieval. In order to enhance organ viability, intravenous medications may be administered, and/or the patient cannulated, whilst the patient is still alive so that the organs can be perfused with appropriate preserving fluids immediately after death is declared. 29 The UK Intensive Care Society (ICS) rejects the USA practice for pre-mortem physical intervention.
The ICS guidelines for NHBD insist that once a decision to withdraw life-sustaining care has been reached:
It is inappropriate to escalate current treatment, add new therapies (e.g. inotropes, heparin, hormone replacement) or to undertake invasive interventions (e.g. vascular cannulation before death for cold perfusion) to improve organ viability … Withdrawal of active treatment should usually take place within the critical care unit. In exceptional circumstances treatment may be withdrawn within the theatre complex (e.g. an anaesthetic room, recovery area). This should be undertaken only as a way of meeting the patient's and relatives' wish to donate organs and not simply as a means of reducing warm ischaemic time. 30 The justification for this policy is not stated in the ICS guidelines but it is likely to be that premortem physical interventions are problematic because they offer no medical benefit to the patienta view with which we are obviously in sympathy. 31 Pre-mortem interventions in the UK are more subtle and take the form of organisational and attitudinal changes to the dying process. In order to reduce warm ischaemic time in controlled NHBD, withdrawal of life-sustaining treatment in the ICU will typically not commence until preparations for donation have been completed and the surgical team are in readiness. The timing of the withdrawal of treatment is chosen to maximise organ viability and not for the benefit of the donor. Similarly, the preferred method of mechanical ventilation discontinuation is to remove the breathing tube from the patient, a method known as terminal extubation, in order to promote a rapid demise, despite the fact that this increases the risk that the patients' relatives will be distressed by the process of their dying.
II -The ethical significance of pre-mortem interventions
Most discussions of the implications of the DDR interpret this rule as prohibiting interventions that bring about the death of the patient in order to harvest a vital organ and in particular those interventions that might bring about the death of the patient by removing a vital organ. That is to say, they interpret the DDR as prohibiting the killing of patients in order to harvest their organs. 323334 We believe that this is an artificially narrow reading of the DDR. In an important discussion of the DDR, Similarly, we hold that the DDR is breached whenever procedures to harvest vital organs are initiated while the patient is still alive.
In practice, controlled NHBD will usually violate the DDR. The pre-mortem procedures that are initiated to minimise warm ischaemic time in NHBD, such as cannulation, and organisational and attitudinal changes that involve the patient being viewed primarily as an organ donor rather than an unconscious intensive care patient, treat a living person as a means to the ends of others. Importantly, these breaches of the DDR are necessary to maximise the chance of successful NHBD, whereas in HBD all donation preparation can await the declaration of death.
It might be objected that we have overstated the significance of the pre-mortem interventions involved in NHBD. In the UK, at least, the changes in the treatment of potential donors involve only organisational and administrative matters, which arguably do not impinge on the welfare of the patient. Even the more robust physical interventions practised in the USA have no impact on the subjective experience of the patient, who is unconscious. It is our impression that the claim that the changes in the care of patients are trivial is the most common response from those working in donation to criticism of controlled NHBD programs. 38 Yet, ethical medical practice consists in not just what patients experience but how they are treatedeven if they are absent or unconscious. As both Kantian and virtue ethics insist, attitudes can be morally significant.
One way of bringing out the troubling nature of the attitudinal changes involved in NHBD is to imagine the logical extension of the pre-mortem interventions that are currently employed to facilitate organ salvage. With appropriate anaesthesia, it would be possible to reduce warm ischaemia even further by surgical exposing the organs to be salvaged before life support was withdrawn. As long as the patient's heart stopped beating as the result of life-sustaining treatment being withdrawn rather than as a result of the preparations for donation, then this procedure would be compatible with an interpretation of the DDR that only prohibited killing the patient. Yet it is clear that, in this scenario, we would be flagrantly violating the ordinary standards of ethical medical practice. Moreover, the real source of the violation here is the fact that we are treating a living patient as though they were dead rather than the details of the particular surgery. This shift in attitude towards the patient is also characteristic of current practices of pre-mortem intervention to facilitate NHBD; it is for this reason that we believe these practices violate the DDR.
III -Consent and the best interests of the patient
That controlled NHBD will usually violate the DDR need not be a decisive objection to it. A number of authorities have previously canvassed the idea that we should abandon the DDR, in part because of the barrier it poses to organ donation. 39404142434445 Abandoning the DDR would shift the burden of establishing that a particular organ salvage is ethically permissible to the question of consent.
We are prepared to entertain the possibility that pre-mortem interventions in the care of a controlled NHB donor may be legitimate if we have informed consent to such interventions from the patient or an appropriate surrogate: that is, consent-either current or prior-that is informed, voluntary, and provided by a competent agent. 464748 However, an unconscious intensive care patient has no current capacity to consent to such procedures. In the absence of prior-or surrogate-consent, that means that doctors must act in a patient's best interest.
All of the UK policies we reviewed for this paper allow for controlled NHBD to commence on the absence of objections from the family and/or registration on the Organ Donor Register (ODR).
Indeed, under the UK Human Tissue Act (HTA) presence on the ODR is defined as legal consent for organ donation. 4950 The use of this standard in NHBD means that the "consent" process for NHBD is exactly the same as used in HBD-another indication that controlled NHBD treats the potential NHB donor as effectively dead already.
More importantly, it is clear that the process of registration on the ODR falls well short of that required to establish informed consent. 51 The educational materials associated with the ODR consist in information designed to encourage donation, with no mention of possible negative consequences of participation in donation; nor is there an opportunity for potential donors to have their individual questions about donation answered. Given these limitations of the ODR, registration should not be held to constitute informed consent to pre-mortem interventions to facilitate NHBD. 52 In countries that allow for surrogate consent, there may well be more opportunity to gain appropriate consent for NHBD. A full discussion of the role of surrogate consent in the treatment of incompetent patients is beyond the scope of this article. However, we would note that surrogate decision makers are typically held to be under the obligation to make decisions they regard are in the patient's best interest and accordance to that person's prior expressed views. Allowing surrogates to consent to treatments that have no medical benefit for the patient would involve a significant shift in the role of such decision makers, which should be (very) ethically controversial. A possible exception would be where the patient has previously expressed strong views about their willingness to undergo particular medical procedures. However, the mere fact of registration on the ODR is insufficient evidence of the existence of such views. However, there are number of reasons to be cautious about this approach as a solution to the ethical problems involved in NHBD. First, preference satisfaction accounts of well-being are controversial and subject to a number of well-known objections. 545556 Second, there is a certain amount of intellectual strain involved in thinking of pre-mortem interventions in the care of a patient designed to facilitate NHBD as motivated by a concern for the best interests of the donor. They are more naturally understood as driven by a concern for the best interests of potential organ recipients. This is not to say that donation and the procedures necessary to facilitate it might not also be in the donor's best interests. However, the strong interests of other parties in the donation process lends weight to the suspicion that the account of well-being supposed here has been chosen for the support it lends to NHBD rather than on its own merits. Third, even on a preference satisfaction account of well-being it is unlikely that the satisfaction of a patient's every preference will be in their best interests. Instead, the extent of the satisfaction of their strong or considered preferences will determine a patient's well-
being. Yet, as we observed above, registration on the ODR is an unreliable indicator that donors have a strong preference to undergo particular procedures. Moreover, fourth, there are good reasons to believe that many patients might object to interventions that treat them as though they were already dead and that may involve assaults on their physical integrity and dignity and/or prove psychologically distressing to their loved ones. In the absence of compelling evidence that a particular patient had strong preferences to allow intervention in the dying process in order to facilitate donation, then, it is inappropriate to judge it to be in a patient's best interests to undergo procedures that are more naturally described as benefiting other people.
Of course, if the salvage of vital organs while the patient is still alive can be justified by securing consent then the question arises why we should continue to put such stock in the distinction between withdrawing treatment and actively euthanising patients? If we are prepared to violate the DDR by beginning the removal of vital organs before death occurs, as long as we have appropriate consent, should we not also be prepared to violate it by killing the patient in the course of doing so-or, indeed, in order to do so? Posing the question in this blunt form highlights the challenge that controlled NHBD poses to the ethical practice of organ salvage and donation.
IV -Redefine Death?
An alternative response to concerns about violations of the DDR in the course of controlled NHBD is to claim that the unconscious and dying intensive care patient is, in all relevant senses, dead already and therefore that it is entirely appropriate for them to be treated in the same way as those who are brain dead. 57 If we are prepared to distinguish between the death of the person -the centre of conscious experience that is worthy of moral regard-and the death of the human organism then we may be able to claim that sometimes while the organism is still alive the person may be dead. If personhood is any of the following: perceiving oneself as existing over time, rationality, possession of preferences, or goal setting; then it might be argued that the unconscious and dying intensive care patient has died prior to donation. 5859 According to this line of thought, controlled NHBD does satisfy the DDR after all.
Whether this distinction is a plausible one and the consequences for medical practice of adopting criteria of death that focused on "death of the person" are questions too large for us to settle here. 60 In this context it will suffice to note just how radical a change in our notion of death such a move would involve. 61 As a number of philosophers have argued, infants are not persons in the sense outlined above, as they lack both future regarding preferences and a sense of themselves as persisting through time. 626364 Similarly, on this account, many individuals at the end of life, particularly those suffering advanced dementia, will be dead for long periods of time before their bodies expire.
Indeed, the "person" may have "died", albeit perhaps only temporarily, whenever a patient is unconscious. Insisting that death involves the irreversible loss of the capacities listed above does not entirely resolve these anomalies (for instance, it cannot explain why it would be directly wrong to kill an infant before they had formulated the desire to stay alive) and has the further consequence of rendering the answer to the question as to whether a patient is dead or not hostage to future events.
As Peter Singer has argued, this "revised" concept of death, shaped to fit a very particular-if widely shared-set of philosophical commitments, is so implausible an account of death that we can only account for it being contemplated at all as a consequence of the desire to make more organs available for transplant, possibly because of utilitarian concerns of the sort we consider below. 6566 Short of this radical revision of our concept of death, NHBD patients are clearly still alive until they have suffered brain death or their hearts have stopped beating.
V -The utilitarian case for NHBD
There is of course a utilitarian justification for controlled NHBD programmes, which argues that any negative impacts of violations of the DDR or of breaches of consent are outweighed by the great benefits provided to the recipients of organs from these programs. We suspect that a vivid awareness of the situation of those awaiting the availability of organs for transplantation, along with the belief that any harms to the donors involved in NHBD, if not trivial, are not of the same order as those confronting potential recipients, serves to justify NHBD programs in the eyes of many of those involved in them.
However, this utilitarian argument is-as is so often the case with utilitarian arguments-much too powerful and would justify policies that are clearly unethical by current standards. For example, John
Harris's notorious "survival lottery", wherein the organs of randomly selected healthy persons would be confiscated and redistributed to the needy sick, can be justified on utilitarian grounds. 67 The ease with which repugnant conclusions can be justified using utilitarian arguments suggests that we should be extremely cautious about abandoning long-held principles of ethical medicine, such as respect for patient autonomy and concern for the best interests of each and every individual under our care, in response to the demands of a utilitarian calculus. 68 If proponents of NHBD wish to justify pre-mortem interventions without consent in NHBD with reference to a utilitarian calculus then it would be best if this were done explicitly and not (mis)represented as a claim about the nature or significance of death. Society would then be able to make a clear choice about whether or not to permit such interventions. 69 We believe that an honest acknowledgement of the fact that, where it involves pre-mortem interventions, controlled NHBD involves taking organs from living patients and must be justified-if, indeed, it can be justified-by reference to the consent of the donor is an essential first step in the debate about the ethics of these practices.
VII -Conclusion
Controlled NHBD offers tremendous opportunities: it also offers new ethical challenges. In practice, NHBD will usually violate the DDR by beginning the procedures to remove vital organs well before the patient is dead. Abandoning the DDR shifts the burden of the argument for ethical NHBD onto the question of consent. We argue that the appropriate consent for medical procedures to be carried out while the patient is still alive is informed consent and that registration on an organ donor registry is itself insufficient to justify pre-mortem interventions in the care of NHBD patients. There may be some scope for ethical pre-mortem intervention in NHB donation where prior consent has been given or where surrogates are capable of drawing on reliable knowledge of a potential donors' own preferences. However, again, the mere fact of registration for organ donation should not be taken to establish the existence of a preference to undergo pre-mortem interventions. The argument that premortem procedures to facilitate donation are in a patient's best interest is tendentious and, in practice, is also likely to founder on difficulties in demonstrating that NHB donors had strong preferences to undergo such procedures. While there may be a utilitarian case to be made for NHBD, any such argument is likely to suffer from the familiar failings of utilitarian arguments: that they sanction the instrumentalisation of persons and can be used to justify intuitively repugnant policies.
It is, therefore, our conclusion that current moves towards more widespread NHBD can only be justified if we are prepared to abandon the Dead Donor Rule. 21 The current recommendations to diagnose death by cardio-pulmonary grounds are a minimum of two minutes of pulselessness, as documented by an absent arterial line waveform, in the USA versus a minimum of 5 minutes of asystole, as documented by the absence of electrical activity by an electrocardiogram in the UK. 25 This is of considerable concern in potentially increasing the number of cases of Lazarus syndrome (autoresuscitation). Theoretically, it also might mean that brain function is re-established. These possibilities in turn place significant pressure on the idea that these patients are dead by either brain or cardiac death criteria, which refer to the irreversible loss of function of these organs. 26 See note 3, Bell 2003:176-81.
